Met Life Investment Management, LLC Soma Logic, Inc. Transaction History

Met Life Investment Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 29, 2024	BUY	$2.1 - $3.36 $174,990 - $279,985	83,329 New	83,329 $192,000
Q1 2023 May 09, 2024	BUY	$2.13 - $3.6 $177,490 - $299,984	83,329 New	83,329 $212 Million
Q1 2023 May 15, 2023	BUY	$2.13 - $3.6 $39,149 - $66,168	18,380 Added 28.3%	83,329 $212,000
Q4 2022 May 10, 2024	SELL	$2.05 - $3.47 $33,150 - $56,113	-16,171 Reduced 19.93%	64,949 $163,000
Q4 2022 Jun 14, 2023	SELL	$2.05 - $3.47 $37,679 - $63,778	-18,380 Reduced 22.06%	64,949 $163,000
Q4 2022 Mar 22, 2023	SELL	$2.05 - $3.47 $33,150 - $56,113	-16,171 Reduced 19.93%	64,949 $163,000
Q4 2022 Feb 15, 2023	SELL	$2.05 - $3.47 $33,150 - $56,113	-16,171 Reduced 19.93%	64,949 $163,000
Q3 2022 Jun 14, 2023	SELL	$0.63 - $5.47 $1,391 - $12,083	-2,209 Reduced 2.65%	81,120 $235,000
Q2 2022 May 10, 2024	BUY	$4.27 - $8.26 $346,382 - $670,051	81,120 New	81,120 $366,000
Q2 2022 Jun 20, 2023	SELL	$4.27 - $8.26 $9,432 - $18,246	-2,209 Reduced 2.65%	81,120 $366,000
Q2 2022 Mar 22, 2023	BUY	$4.27 - $8.26 $69,050 - $133,572	16,171 Added 24.9%	81,120 $366,000
Q2 2022 Aug 11, 2022	BUY	$4.27 - $8.26 $346,382 - $670,051	81,120 New	81,120 $367,000

7.48M

Ticker SLGC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 183,452,992
Description
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.